IMC Chicago
GSK icon

IMC Chicago’s GSK GSK Stock Holding History

IMC Chicago’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,319
Closed -$1.93M – 4206
2025
Q3 		$1.78M Buy
+41,319
New +$1.61M ﹤0.01% 2311
2024
Q2 		– Sell
-25,852
Closed -$1.09M – 2678
2024
Q1 		$1.11M Buy
25,852
+1,227
+5% +$50.6K ﹤0.01% 1675
2023
Q4 		$913K Buy
24,625
+486
+2% +$17.4K ﹤0.01% 1466
2023
Q3 		$875K Buy
+24,139
New +$857K ﹤0.01% 1266
2023
Q1 		– Sell
-65,860
Closed -$2.3M – 1315
2022
Q4 		$2.31M Buy
65,860
+27,172
+70% +$905K ﹤0.01% 773
2022
Q3 		$1.14M Buy
+38,688
New +$1.47M ﹤0.01% 894
2021
Q1 		– Sell
-12,094
Closed -$549K – 1094
2020
Q4 		$556K Sell
12,094
-3,293
-21% -$151K ﹤0.01% 937
2020
Q3 		$724K Buy
+15,387
New +$771K ﹤0.01% 793

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago's GSK Position: Q4 2025 in Review

IMC Chicago sold out of GSK (GSK) in Q4 2025, closing a stake of 41,319 shares — an estimated $1.93M sold.

IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters. The position peaked at $2.31M in Q4 2022. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • IMC Chicago reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 41,319 GSK shares in Q4 2025, an estimated $1.93M.
  • IMC Chicago first reported a position in GSK in Q3 2020 and held it in 8 quarters.
  • IMC Chicago's GSK position peaked at $2.31M in Q4 2022.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.